MedTrace Logo

Mindfulness for Irritable Bowel Syndrome

NCT02794376 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2017-10-27

No results posted yet for this study

Summary

This study investigates the effectiveness of a 6 week mindfulness intervention in reducing symptoms of Irritable Bowel Syndrome (IBS). All Participants will receive treatment. Participants will be randomly allocated to an immediate treatment group and a waiting list control group.

Conditions

  • Irritable Bowel Syndrome

Interventions

BEHAVIORAL

Mindfulness Based Cognitive Therapy (MBCT)

BEHAVIORAL

Waiting Period

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-14
Primary Completion
2017-07-10
Completion
2017-07-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02794376 on ClinicalTrials.gov